|
Cancer Cell Metabolism Inhibitors for Targeted Therapies
Application
Glutamate dehydrogenase (GDH1) inhibitors targeting cancer cell metabolic pathways.
Key Benefits
Targets tricarboxylic acid (TCA) cycle/mitochondrial metabolism utilized by several cancer cell types for cell growth and survival.
Reduces cell proliferation and viability in several tumor derived cell lines as well as in xenograft tumor...
Published: 4/23/2024
Contributor(s): Sumin Kang, Jing Chen, Lingtao Jin
|